Semaglutide

Who Qualifies for Semaglutide? GLP-1 Weight-Loss Eligibility for Florida Adults

BMI guidelines, health conditions and safety screening that shape GLP-1 eligibility, explained by a Florida nurse practitioner.

Amanda Walrath, APRN, FNP-BCNovember 1, 2026

Have questions about your own care? Book your free consult with Amanda by video, available to adults anywhere in Florida.

A patient at home on a video visit with a Nuvo provider

Considering semaglutide? Nuvo offers compounded semaglutide in Stuart, FL and by telehealth across Florida, $400 per vial with a free consult.See semaglutide →

Who qualifies for semaglutide is usually the very first question people ask when they reach out to us, and it's a smart place to start. Eligibility for a GLP-1 weight-loss medication isn't decided by a quiz or a number on the scale alone. It comes down to your health history, your current medications, your goals, and a clinical evaluation with a licensed provider.

I'm Amanda Walrath, APRN, FNP-BC, a Florida-licensed, board-certified family nurse practitioner with 17 years of clinical experience and the founder of Nuvo Wellness and Health. I started Nuvo after my own weight-loss struggle after having kids, and I've taken the same medication I offer. In this guide I'll walk you through the general guidelines providers use, the health factors that matter, who should be cautious, and what the screening process looks like when you start care with us by telehealth anywhere in Florida.

Compounded semaglutide and tirzepatide are not FDA-approved, and they are not the same as, equivalent to, or generic versions of any brand-name medication. Whether treatment is appropriate for you is decided by a clinical evaluation. Individual results vary.

Who qualifies for semaglutide? The general BMI guidelines

FDA-approved GLP-1 medications for chronic weight management are labeled for adults who meet one of these body mass index (BMI) guidelines, and providers commonly use the same framework as a starting point when considering GLP-1 treatment for weight loss:

Guideline

BMI

Additional requirement

Obesity range

30 or higher

None beyond a clinical evaluation

Overweight range

27 to 29.9

At least one weight-related health condition

Below 27

Under 27

Generally not a candidate for GLP-1 weight-loss treatment

BMI is an estimate based on your height and weight. It isn't perfect, since it doesn't measure muscle, body fat distribution or overall fitness, but it gives your provider a consistent place to begin. You can find a free BMI calculator from the CDC or NIH online if you'd like to check yours before your visit.

Weight-related conditions that factor into GLP-1 eligibility

If your BMI falls between 27 and 29.9, your provider will look for at least one weight-related condition. Common examples include:

–High blood pressure

–Prediabetes or type 2 diabetes

–High cholesterol or triglycerides

–Obstructive sleep apnea

–Heart disease

You don't need a formal diagnosis in hand before booking. Part of the evaluation is reviewing your history together, and in some cases your provider may recommend lab work or ask about recent results from your primary care provider.

Who should not take semaglutide or should be especially cautious

Meeting the BMI guideline is only half the picture. Safety screening matters just as much, and these are some of the factors I always discuss with patients before prescribing semaglutide or tirzepatide:

–A personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2). GLP-1 medications are not used in these situations.

–Pregnancy, breastfeeding, or planning a pregnancy. These medications are not recommended during pregnancy, and your provider will talk with you about timing if you're planning one.

–A history of pancreatitis.

–Gallbladder disease or a history of gallstones.

–Kidney problems, especially if you're prone to dehydration.

–Diabetic retinopathy or other diabetic eye disease.

–Severe stomach or digestive conditions, such as gastroparesis.

–Type 1 diabetes, or taking insulin or a sulfonylurea, which can raise the risk of low blood sugar when combined with a GLP-1.

–A history of depression or thoughts of self-harm, which your provider should know about so they can monitor you.

–A past allergic reaction to semaglutide, tirzepatide or a similar medication.

Having one of these doesn't always mean you can't be treated, but it does mean the decision needs a careful, honest conversation. If you take birth control pills, mention that too, because tirzepatide in particular may make oral contraceptives less effective for a period of time after starting or increasing a dose.

What the semaglutide eligibility screening looks like at Nuvo

Because Nuvo is a telehealth-only practice, your entire evaluation happens by video visit from home. Here's what I review with every patient:

1.Your height, weight and BMI, plus your weight history and what you've tried before.

2.Your medical history, including the conditions listed above.

3.Every medication and supplement you take, so we can check for interactions.

4.Your family history, especially thyroid cancer.

5.Your goals, schedule and comfort level with a weekly self-injection.

6.Whether semaglutide or tirzepatide is a better fit, or whether neither is appropriate right now.

If GLP-1 treatment isn't the right choice for you, I'll tell you honestly and explain why. Sometimes the best next step is to talk with your primary care provider, address another health issue first, or focus on nutrition, movement and sleep.

Qualifying for semaglutide vs. tirzepatide

The general eligibility guidelines for semaglutide and tirzepatide are very similar, and the same safety screening applies to both. The choice between them depends on your health history, how you've responded to medications in the past, side effects, and budget. At Nuvo, compounded semaglutide 2.5 mg/mL is $400 per 4 mL (10 mg) vial, and compounded tirzepatide 15 mg/mL is $500 per 4 mL (60 mg) vial. Each vial lasts about 12 weeks depending on your dose, and medication, supplies, shipping and ongoing follow-up are included, with no monthly membership.

If you do start treatment, Nuvo's GLP-1 Patient Guide covers storage, injections and when to call, and our semaglutide dosage chart post explains how doses translate into syringe units.

How to get started with Nuvo

1.Book your complimentary initial consultation online or call or text (772) 210-4649.

2.Meet with me by telehealth video visit for your clinical evaluation.

3.If treatment is appropriate, I'll send your prescription to the pharmacy. Allow 5 to 7 days for the pharmacy to prepare and ship your medication.

4.Your medication ships overnight cold via FedEx to your door. Keep it refrigerated.

5.Follow up by telehealth whenever you need to or at refill time. If you ever miss a dose, call or text us for guidance.

Our hours are Monday through Friday 9 to 5 and Saturday 10 to 2. You can book at nuvowellnessandhealth.janeapp.com or learn more at nuvowellnessandhealth.com.

Frequently asked questions

What BMI do you need to qualify for semaglutide?

FDA-approved GLP-1 medications for weight management are labeled for adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition such as high blood pressure, type 2 diabetes or high cholesterol. Final eligibility is decided by a clinical evaluation.

Can I get semaglutide if I don't have diabetes?

Yes, people without diabetes may be candidates for GLP-1 weight-loss treatment if they meet the BMI guidelines and pass safety screening. Your provider will review your full health history before prescribing.

Who should not take semaglutide?

People with a personal or family history of medullary thyroid carcinoma or MEN2, and people who are pregnant, should not take it. A history of pancreatitis, gallbladder disease, kidney problems, diabetic eye disease or severe digestive conditions must be discussed with your provider first.

Do I need lab work to qualify for semaglutide?

Not always. Some patients are asked for recent lab results or new labs depending on their health history and current medications. Your provider will let you know during your evaluation.

Can I find out if I qualify for semaglutide online in Florida?

Yes. Nuvo offers a complimentary initial consultation and a telehealth clinical evaluation for adults anywhere in Florida, with no office visit needed.

If you're taking a GLP-1 medication and develop severe or persistent stomach pain, vomiting, signs of an allergic reaction, or symptoms of dehydration, contact your provider right away or seek urgent care.

This article is for educational purposes and is not medical advice. Compounded medications are not FDA-approved. Prescriptions are issued only after a medical evaluation determines treatment is appropriate. Individual results vary.